Results 31 to 40 of about 8,514 (172)

Factors influencing successful radioiodine therapy of thyroid [PDF]

Archive of Oncology, 2003
Background: Well-known fact is that the good surgical treatment, leaving only small residuals of thyroid tissue, is the outmost valid predictive factor of successful ablative radioiodine treatment. Assuming that all patients had state of the art surgical
Popadić Silvija M., Vojičić Jelena V., Peter Andrea, Malešević Milica Đ., Mihailović Jasna, Kermeci Katarina   +5 more
doaj   +1 more source

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

Frontiers in Endocrinology, 2022
BackgroundSubclinical thyrotoxicosis (SCT) is associated with significant morbidity and mortality, specifically increased risk of atrial fibrillation and cardiovascular death.
Jason Phowira, Jason Phowira, Katherine L. Coffey, Katherine L. Coffey, Katherine L. Coffey, Peter H. Bartholomew, Peter H. Bartholomew, Nicholas Vennart, Nicholas Vennart, Matheus Moreira, Matheus Moreira, Hannah Emerson, David Kennedy, Jolanta U. Weaver, Jolanta U. Weaver   +14 more
doaj   +1 more source

Reassessing Radioactive Iodine Use After Thyroidectomy in Low‐Risk Differentiated Thyroid Cancer: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Routine radioactive iodine (RAI) after thyroidectomy in low‐risk differentiated thyroid cancer shows no clear benefit in reducing recurrence or improving survival. These findings support a selective, risk‐based approach, avoiding unnecessary treatment and potential adverse effects.
Maheen Asif, Mudasar Nisar, Aliza Asif, Makzooma Batool, Rabia Javed Iqbal, Mohammed Hammad Jaber Amin   +5 more
wiley   +1 more source

Thyroid cell irradiation by radioiodines: a new Monte Carlo electron track-structure code

Brazilian Archives of Biology and Technology, 2007
The most significant impact of the Chernobyl accident is the increased incidence of thyroid cancer among children who were exposed to short-lived radioiodines and 131-iodine.
Christophe Champion, Mouhamad Elbast, Ting-Di Wu, Nicole Colas-Linhart   +3 more
doaj   +1 more source

Prostate Cancer Development, Progression, and Therapy

MedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin, Zicheng Xiao, Zexian Ding, Wei Li, Ruijiang Zeng, Yujun Shuai, Weimin Ci, Dan Xia, Xu Zhang, Haojie Huang   +9 more
wiley   +1 more source

The seven-year preliminary results of brachytherapy with Iodine-125 seeds for localized prostate cancer treated at a Brazilian single-center

International Brazilian Journal of Urology, 2007
OBJECTIVE: To report the seven-year preliminary results of a single-center on brachytherapy with Iodine-125 seeds, used in combination with external beam radiotherapy in selected patients with localized prostate cancer (T1-T2). MATERIALS AND METHODS: All
Carlos A. S. Franca, Sergio L. Vieira, Antonio J. S. Bernabe, Antonio B. R. Penna   +3 more
doaj   +1 more source

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/ total thyroidectomy.
Raj Kumar Badam, Jyotsna Suram, Dara Balaji Gandhi Babu, Shefali Waghray, Rahul Marshal, Sharath Chandra Bontha, Reddy Lavanya, Sudheer Kanth   +7 more
doaj   +1 more source

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

Advanced Science, Volume 13, Issue 46, 17 August 2026.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma, Rui Guo, Dongfeng Niu, Yufei Song, Zhenyao Zhang, Xiangxi Meng, Lili Mao, Haifeng Huang, Hua Zhu, Zhi Yang, Teli Liu   +10 more
wiley   +1 more source

Longitudinal Tracking of Astrocyte Reactivity During the Development of Chronic Orofacial Neuropathic Pain Using [18F]‐SMBT‐1 Positron‐Emission Tomography

Glia, Volume 74, Issue 8, August 2026.
Using [18F]‐SMBT‐1 PET, we longitudinally tracked MAO‐B–expressing reactive astrocytes during orofacial neuropathic pain development in rats, revealing region‐ and time‐specific astrocyte activation during pain chronification. ABSTRACT Chronic neuropathic pain represents a significant global health burden and is hypothesized to be maintained by an ...
Lewis S. Crawford, James W. M. Kang, OIivia I. Davanzo, Hyunsol Lim, Sabrina Salberg, Marissa Srgo, Crystal Li, Gaelle M. Emvalomenos, Bianca Jupp, Matthew Long, Wayne Noonan, Mohammad B. Haskali, Richelle Mychasiuk, Kevin A. Keay, Luke A. Henderson   +14 more
wiley   +1 more source

Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer

Heliyon, 2023
Background: Iodiene-131 (131I) treatment is the primary therapeutic approach for imaging 131I-avid pulmonary metastases. The response to radioiodine (RAI) treatment is an important prognostic factor in patients with pulmonary metastases from ...
Xin-Yu Wu, Bo Li, Jie Zhang, Li-Li Duan, Bing-Xin Hu, Yong-Ju Gao   +5 more
doaj   +1 more source